Ironwood is a healthcare company dedicated to making a difference for people living with gastrointestinal (GI) diseases

Media Releases
May 27, 2020

Ironwood and AbbVie Report Top-line Phase II Data for MD-7246 in Patients with Abdominal Pain Associated with Irritable Bowel Syndrome with Diarrhea (IBS-D)

May 6, 2020

Ironwood Pharmaceuticals Reports First Quarter 2020 Results and Provides Update on Impact of COVID-19 Pandemic

Learn About Our Pipeline

View

Interested in Joining Our Team?

View

Copyright © 2020, Ironwood Pharmaceuticals, Inc. All Rights Reserved

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.

You are now leaving www.IronwoodPharma.com.

This link will take you to a website to which our privacy policy does not apply. You are solely responsible for your interactions with that website.